Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06840288 · ClinicalTrials.gov registry record
Bronchoscopic Lung Ablation of Small Thoracic Tumors: the Blastt Registry
A clinical trial of Thoracic Tumors, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 250
- Enrollment target
- 1
- Study location
NCT06840288: Recruiting study of Thoracic Tumors, sponsored by M.D. Anderson Cancer Center.
NCT06840288 is a study of Thoracic Tumors that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 250 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06840288, a study of Thoracic Tumors, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
To aggregate, integrate, and analyze data facilitating the study of MD Anderson patients with a known diagnosis of lung cancer or metastases to the lungs who undergo robotic assisted bronchoscopic ablation of peripheral tumors.
Conditions Studied
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2025-02-19 |
| Est. Completion | 2036-12-31 |
What NCT06840288 shows while recruiting
NCT06840288 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Thoracic Tumors appearing as the primary indexed condition, and to 0 interventions.
NCT06840288 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06840288 about?
NCT06840288 is a clinical study titled "Bronchoscopic Lung Ablation of Small Thoracic Tumors: the Blastt Registry". To aggregate, integrate, and analyze data facilitating the study of MD Anderson patients with a known diagnosis of lung cancer or metastases to the lungs who undergo robotic assisted bronchoscopic ablation of peripheral tumors.
What is the current status of trial NCT06840288?
This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2025-02-19. Estimated completion is 2036-12-31.
What conditions does trial NCT06840288 study?
This clinical trial studies the following conditions: Thoracic Tumors.
Who is sponsoring clinical trial NCT06840288?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06840288 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thoracic Tumors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI